why choose us

Clinical Trials Search

Showing 10,640 of 132,963 result(s)
Phase 2;3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines

Status: ACTIVE_NOT_RECRUITING

Condition: COVID-19

Interventions: Coformulated prototype SARS-CoV-2 rS vaccine with Matrix-M adjuvant: supplied as a solution for preparation for injection, at a concentration of 10 ?g

Date: 2023-06-27

Intervention Utilizing a Computerized Cognitive Rehabilitation Program (D-kit;EF1)

Status: Completed

Condition: Mild Intellectual Disability

Interventions:

D-kit;EF1 delivers interventions through online platforms and can be downloaded to smart devices through the iOS App store or Google Play Stor

Date: 2023-06-27

Community-based Implementation of Online EmReg

Status: Completed

Condition: Traumatic Brain Injury

Interventions: A Web-based group intervention to improve emotion regulation in individuals with traumatic brain injury (TBI).
Online EmReg is a 3-hour on-demand

Date: 2023-06-27

A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: Specified dose on specified days

Date: 2023-06-27

A Clinical Study of V940 Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Status: Completed

Condition: Melanoma

Interventions: IM injection

Date: 2023-06-27

Persea Americana for Total Health (PATH)-2

Status: Completed

Condition: Overweight and Obesity

Interventions: The intervention treatment will contain avocado

Date: 2023-06-27

Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas

Status: Completed

Condition: Infant Development

Interventions: Growth Monitoring Study of Infant Formula fed to Healthy Term Infants over a 16 week period

Date: 2023-06-27

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Status: COMPLETED

Condition: Stroke, Ischemic

Interventions: Participants will be provided with a selection of beauty products items including foundation, concealer, blush, highlighter, and lipstick, specificall

Date: 2023-06-27

A2-ESO-1 TCR-Engineered T Cells for Relapsed;Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

Status: NOT_YET_RECRUITING

Condition: Triple Negative Breast Cancer

Interventions: Given IV

Date: 2023-06-27

A Study to Assess the Effects of Epetraborole on the QT Interval in Healthy Adult Subjects

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: Treatment A (Therapeutic): 500 mg epetraborole (2 x 250 mg tablets) and epetraborole matching-placebo (6 tablets)

Date: 2023-06-27